4 posts tagged with "regulatory-affairs"

Kalshi just launched biotech prediction markets as a pilot program, letting the public bet on outcomes like FDA approvals and clinical trial results. We think that's a serious mistake.

The clinical world is full of questions, exceptions, and ambiguity. We built Rightview CRX to help coordinators navigate it.

This is a truly international summer, with the World Cup in full swing and the energy at DIA 2026 Annual Meeting, which brought together a global audience including top regulators from the FDA, UK's MHRA, and Japan's PMDA. These agencies shared interesting data across GCP inspections and spoke on the future of drug development.

We're excited to announce the launch of Rightview CRx — a one-of-its-kind free regulatory Q&A resource built for busy clinical research professionals.